A comprehensive view of Hospital/Clinical Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Gilead resubmits application to FDA for approval of long-acting injectable HIV drug lenacapavir after FDA refused authorization in February due to drug’s compatibility with borosilicate glass vial; Gilead now using aluminosilicate glass vial for drug
Published: June 29, 2022 by SeeNews Pharmaceuticals
Novartis reports 78.8% of multiple sclerosis patients given continuous treatment with injectable drug Kesimpta ofatumumab have no relapse, worsening or condition, disease activity after four years of treatment; Kesimpta had sales of US$195M in Q1
Published: June 29, 2022 by SeeNews Pharmaceuticals
Pfizer, Roivant Sciences announce Priovant Therapeutics JV; Priovant focused on developing autoimmune disease therapies including oral brepocitinib, a potential first-in-class dual inhibitor of TYK2 and JAK1to treat multiple severe autoimmune diseases
Published: June 29, 2022 by Business Wire
Dr. Reddy’s acquires Eton Pharma’s branded, generic injectable drugs for US$50M; deal compliments Dr. Reddy’s US institutional business, includes Biorphen phenylephrine hydrocholoride, Rezipres ephedrine hydrochloride, Cysteine hydrochloride
Published: June 28, 2022 by Marketline - Deals
Celgene’s US$6.4B lawsuit against Bristol Myers Squibb over contingent payouts for three therapies can continue US district court rules; Celgene shareholders allege Bristol Myers did not make sufficient effort to have drugs approved by FDA
Published: June 28, 2022 by SeeNews Pharmaceuticals

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count